|
Volumn 14, Issue 8, 2003, Pages 729-733
|
Failure of peripheral arterial thrombolysis due to elevated plasminogen activator inhibitor type 1.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
FIBRINOGEN;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
TISSUE PLASMINOGEN ACTIVATOR;
UROKINASE;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
DRUG ANTAGONISM;
FEMALE;
FIBRINOLYTIC THERAPY;
HUMAN;
MALE;
METABOLISM;
PERIPHERAL VASCULAR DISEASE;
PHYSIOLOGY;
RISK FACTOR;
THROMBIN TIME;
THROMBOSIS;
TREATMENT FAILURE;
FEMALE;
FIBRINOGEN;
HUMANS;
MALE;
PERIPHERAL VASCULAR DISEASES;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
RISK FACTORS;
THROMBIN TIME;
THROMBOLYTIC THERAPY;
THROMBOSIS;
TISSUE PLASMINOGEN ACTIVATOR;
TREATMENT FAILURE;
URINARY PLASMINOGEN ACTIVATOR;
|
EID: 4344694403
PISSN: 09575235
EISSN: None
Source Type: Journal
DOI: 10.1097/00001721-200312000-00006 Document Type: Article |
Times cited : (8)
|
References (0)
|